T1	Participants 54 79	sextant prostate biopsies
T2	Participants 370 411	patients undergoing radical prostatectomy
T3	Participants 446 493	118 patients with biopsy proved prostate cancer
T4	Participants 1121 1175	patients with negative versus positive repeat biopsies
